Clinical Trial Update: Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluates safety and preliminary efficacy of combining CpG 7909 with trastuzumab (Herceptin) in patients with metastatic breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CPG 7909 (CpG 7909)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Metastatic Breast | Phase 1, Phase 2 | Status: COMPLETED